Literature DB >> 8700311

Gamma knife radiosurgery for brain tumors: postirradiation volume changes compared with preradiosurgical growth fractions.

M Yamamoto1, M Ide, Y Umebara, S Hagiwara, M Jimbo, K Takakura.   

Abstract

The postradiosurgical volume changes were compared with preradiosurgical growth fractions defined as the tumor doubling time and/or MIB-1 staining index in 14 patients who underwent gamma knife radiosurgery for treatment of various brain tumors. The mean preradiosurgical observation period using neuroimaging techniques was 750 days (range 80-2967 days), and the mean follow-up period after radiosurgery was 664 days (range 328-1100 days). There were four neurinomas, three meningiomas, two craniopharyngiomas, two gliomas, one hemangioblastoma, one pituitary tumor, and one intracranially infiltrative lacrimal gland tumor. The mean patient age at the time of radiosurgery was 52 years (range 8-81 yrs). There were eight males and six females. Following gamma knife radiosurgery, the mean tumor half time was estimated to be 789 days (range 124-2101 days), and the volume reduction against the preradiosurgical tumor volume ranged from 6.3% to 76.1%. This study demonstrates that gamma knife radiosurgery can control tumor growth despite the lack of a correlation with preradiosurgical tumor growth or staining indices for MIB-1. Analyses of this type are essential to show that an "unchanged tumor volume" as demonstrated by postradiosurgery follow-up neuroimaging can be regarded as showing successful radiosurgery.

Entities:  

Mesh:

Year:  1996        PMID: 8700311     DOI: 10.2176/nmc.36.358

Source DB:  PubMed          Journal:  Neurol Med Chir (Tokyo)        ISSN: 0470-8105            Impact factor:   1.742


  2 in total

1.  Serial follow-up MR imaging after gamma knife radiosurgery for vestibular schwannoma.

Authors:  H Nakamura; H Jokura; K Takahashi; N Boku; A Akabane; T Yoshimoto
Journal:  AJNR Am J Neuroradiol       Date:  2000-09       Impact factor: 3.825

2.  Stereotactic radiosurgery in hemangioblastoma: Experience over 14 years.

Authors:  Nishant Goyal; Deepak Agrawal; Raghav Singla; Shashank Sharad Kale; Manmohan Singh; Bhawani Shankar Sharma
Journal:  J Neurosci Rural Pract       Date:  2016 Jan-Mar
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.